North America Hypodermic Needles Market Report and Forecast 2025-2034

The North America hypodermic needles market was valued at USD 1.63 billion in 2024, driven by the increasing prevalence of chronic diseases and rising innovation in needle technology in the region. The market is expected to grow at a CAGR of 7.00% during the forecast period of 2025-2034, reaching a value of USD 3.20 billion by 2034 .

North America Hypodermic Needles Market Analysis

Hypodermic needles are hollow needles utilized for fast delivery of fluids (medications or vaccines) into the patient's body. They are also used for blood administration and transfusions. Older adults are more prone to developing a chronic condition that often requires frequent injections, leading to increased use of these medical tools in healthcare settings which impacts the global hypodermic needles market dynamics. Further, the rising improvements in needle manufacturing processes such as automation and precision engineering are expected to enhance the quality of this product and drive the North America hypodermic needles market growth.

In the United States, around 129 million people have at least 1 major chronic disease including cancer, heart disease, and hypertension. Further, the proportion of people living with multiple chronic conditions is increasing rapidly in America . The rising burden of chronic health issues augments the need for hypodermic needles for the efficient delivery of injectables. Moreover, there is a shift towards home healthcare, and the self-administration of medications, such as insulin for diabetes and biologics for autoimmune diseases, which directly influences the North America hypodermic needles market demand.

In January 2023, leading med-tech manufacturer MTD Group's affiliate Pikdare S.p.A. received the United States Food and Drug Administration (FDA) approval for its innovative injection needle, DropSafe Sicura passive safety needle, which boasts a fully passive mechanism that can be utilized for the subcutaneous and intramuscular injection of vaccines and other drugs. This passive safety needle can help eliminate needlestick injuries, with the needle being protected by a transparent shield designed to lock automatically after injection. Thus, the healthcare professional doesn't require any incremental activation step after the injection. The rising introduction of advanced passive safety-engineered devices for safe drug delivery is poised to elevate the market value in the forecast period.

North America Hypodermic Needles Market Segmentation

The report titled “North America Hypodermic Needles Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:

Market Breakup by Usage

• Disposable
• Reusable
• Others

Market Breakup by Product Type

• Safety Hypodermic Needles
• Non-Safety Hypodermic Needles

Market Breakup by Application

• Drug Delivery
• Vaccination
• Blood Specimen Collection

Market Breakup by End User

• Hospitals
• Cancer Treatments Centers
• Dermatology Clinics
• Others

Market Breakup by Region

• United States
• Canada

Leading Players in the North America Hypodermic Needles Market

The key features of the market report include partnerships, and collaborations analysis by the leading market players. The major companies in the market are as follows:

EXELINT International, Co.

This company manufactures and distributes disposable medical health care products including siliconized, autoground needle points to ensure maximum patient comfort.

Terumo Corporation

Terumo Corporation is a leading provider of medical devices and supplies. Its hypodermic needles are precision-manufactured to guarantee maximum sharpness.

Becton, Dickinson and Company

This American multinational medical technology company is a key manufacturer of high-quality and easy-to-use safety injection needles and syringes.

B. Braun Melsungen AG

This German medical and pharmaceutical device company has a prominent presence in the market. Its hypodermic needles have a light silicone coating to provide a smooth surface and minimize discomfort.

Other players in the market include Catalent Inc., Cardinal Health Inc., Vita Needle Company, Connecticut Hypodermics Inc., Vygon, Barber of Sheffield, and Retractable Technologies, Inc.

This product will be delivered within 3-5 business days.